Stock Market

NVAX Stock Alert: Novavax Just Hit a New 52-Week High

Source: benjamin poturak /

Novavax (NASDAQ:NVAX) stock investors are celebrating on Friday as the vaccine company’s shares hit a new 52-week high after announcing a deal with Sanofi (NASDAQ:SNY).

This saw shares of NVAX stock climb as high as $9.22 per share during normal trading hours on Friday. That comes with some 142 million shares of the stock changing hands. For the record, this is well above its daily average of about 6.8 million shares.

Investors will note that NVAX stock hasn’t been in this range since September 2022. However, it’s still a far cry from its previous highest price of $290.18 per share. It’s worth noting that Novavax stock reached that price during the height of the Covid-19 pandemic.

The Sanofi deal includes a co-exclusive licensing agreement with Novavax. This covers its Covid-19 vaccine. It also has Sanofi taking a minority stake of less than 5% in the company.

JPMorgan Upgrades NVAX Stock

Alongside all of this positive news comes an upgrade from JPMorgan analysts. This has it increasing its rating for NVAX stock from “underweight” to “neutral.” That’s still a bit bearish compared to the analysts’ consensus rating of moderate buy based on three opinions.

NVAX stock is up 97.3% as of Friday afternoon and is up 75.4% since the start of the year.

There are more stock market stories traders need to read about today below!

We have all of that info good to go with out coverage of the stock market. That includes what’s going on with shares of Oklo (NYSE:OKLO) stock, another update on NVAX shares and more. All of this news is available below!

More Stock Market News for Friday

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines.

Article printed from InvestorPlace Media,

©2024 InvestorPlace Media, LLC

Source link

Share with your friends!

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest stocks updates
straight to your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.